Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
HIVE Digital Surges on $220M AI Cloud Deal with Bell and Cohere
HIVE Digital Technologies shares rose 11% premarket after a $220 million GPU cloud deal with Bell AI Fabric and Cohere, adding $70 million in annual recurring revenue.
AT&T Stock Dips as CFO Retirement Nears and Fiber Costs Weigh
AT&T shares slipped to $22.37 premarket on CFO transition news, as investors weighed heavy fiber and 5G costs, Verizon's competitive moves, and potential disruption from SpaceX's Starlink.
AT&T Shares Stabilize After CFO Change and FCC Review of Legacy Voice Services
AT&T shares steadied at $22.44 after a 3.1% drop, with investors weighing CFO changes and FCC review of legacy voice service discontinuation.
Super Micro Dips on $7B Equity Raise and Jane Street Stake
Super Micro Computer shares dropped 4.9% to $27.78 after unveiling a $7 billion equity raise for AI server parts and Jane Street Group's 8.5% stake, fueling dilution worries.
Keel Infrastructure's AI Data Center Push and Auditor Change Draw Investor Scrutiny
Keel Infrastructure traded at $6.2037 in premarket as investors weighed its $458M convertible debt raise, auditor change, and U.S. domicile shift. Revenue fell 23% and adjusted EBITDA turned negative in Q1.
Nokia Rallies on Lenovo Patent Pact and AI-Driven Optical Expansion
Nokia gained 1.3% to €12.20 on a Lenovo patent pact and optical/defense updates, but undisclosed terms and a 119% YTD surge raise the bar for earnings on July 23.
IceCure Medical Surges on ProSense Uptick and $5.5M Financing
IceCure Medical shares soared 200% after revealing a 70% jump in U.S. ProSense breast cancer cryoablation installs and a $5.5 million private placement, as the market balances rapid adoption against potential dilution.
Plug Power Shares Stagnate as Dilution Fears and Cash Concerns Persist
Plug Power shares remain under pressure after a shareholder vote to expand equity incentives, with dilution fears and a pending asset sale keeping liquidity in focus.
AMC Holds Steady After Heavy Volume Rally, Debt Concerns Linger
AMC shares held at $2.66 after a heavy-volume rally, as investors weigh record May attendance and a $150M equity sale against $4.02B debt.
UniQure Holds Gains as FDA Signals Path for Huntington's Gene Therapy Filing
UniQure shares jumped 78.4% after the FDA said Phase I/II data could support an accelerated-approval filing for its Huntington's disease gene therapy AMT-130. A BLA is planned for Q3 2026.
